Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02IQP
|
||||
Former ID |
DNC013502
|
||||
Drug Name |
1-(oxazolo[4,5-b]pyridin-2-yl)pentan-1-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529193] | ||
Structure |
Download2D MOL |
||||
Formula |
C11H12N2O2
|
||||
Canonical SMILES |
CCCCC(=O)C1=NC2=C(O1)C=CC=N2
|
||||
InChI |
1S/C11H12N2O2/c1-2-3-5-8(14)11-13-10-9(15-11)6-4-7-12-10/h4,6-7H,2-3,5H2,1H3
|
||||
InChIKey |
FBFLUTUPSIYUIG-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529193] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.